Accendra Health (ACH) Q2 FY26 earnings call

Accendra Health reported a challenging Q2 FY26, missing expectations due to slower revenue growth and significant headwinds from payer collection issues, which negatively impacted both revenue and EBITDA. The company has revised its full-year guidance downwards but is implementing cost reduction initiatives and securing new commercial agreements, expecting a stronger Q4 to set the stage for 2027. The CEO also announced his retirement by year-end, initiating a succession process.